October drug roundup: 13 new indicationsGet the info you need on these new indications, part of our drug news roundup for October. Pharmacist guilty of negligence after a patient misused a medicationThe Disciplinary Board criticized the pharmacist for not directly explaining how to safely use the product. In response to pharmacists' outcry over this and other recent harsh penalties, the Board trustee resigned. Myo-inositol doesn’t lower risk of pregnancy complications in PCOS patients: study When compared to a placebo, myo-inositol supplements did not reduce incidences of pregnancy complications in people with PCOS. Drug News—October 2025 A review of new launches, new indications, new dosage forms and Health Canada advisories. New topical JAK inhibitor available for treating chronic hand eczema Anzupgo (delgocitinib topical cream) is indicated for the treatment of moderate to severe chronic hand eczema in adults. NEW PRODUCT: Hepcludex for hepatitis D Get the info you need on this new product, part of our drug news roundup for October. Obesity: Why do so many patients abandon GLP-1 agonists? Despite the hype surrounding GLP-1 receptor agonists, a significant proportion of patients discontinue treatment after a few months, reducing the chances of long-term benefits. Pharmacological treatment of COPD There are evidence-based ways to make a difference for patients. NEW PRODUCT: Alyftrek for cystic fibrosis Get the info you need on this new product, part of our drug news roundup for October. How doctors can help patients get ahead of extreme nausea and vomiting in pregnancy Up to 31% of patients with Hyperemesis Gravidarum stop meds because of side effects. First Previous 4 5 6 7 8 Next Last
